Xintela

Xintela FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Xintela (XINT.ST) as of Oct 21, 2026 is 171.39 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 103.86 % — a change of 65.02% (higher).

FCF Conversion

171.39 %

YoY

65.02%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Xintela is 2025 171.39 % . FCF Conversion Rate (FCF/EBITDA) of Xintela was 2024 103.86 % . It decreases by 65.02% higher compared to the previous year.

The Xintela FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
165.38 SEK
Jan 1, 2019
74.66 SEK
Jan 1, 2020
41.03 SEK
Jan 1, 2021
74.91 SEK
Jan 1, 2022
59.80 SEK
Jan 1, 2023
98.40 SEK
Jan 1, 2024
103.86 SEK
Jan 1, 2025
171.39 SEK
The Xintela FCF Conversion history
YEARFCF ConversionYoY
171.39 %+65.02%
103.86 %+5.55%
98.40 %+64.55%
59.80 %-20.17%
74.91 %+82.59%
41.03 %-45.05%
74.66 %-54.85%
165.38 %+120.69%
74.94 %-25.34%
100.37 %+11.20%
90.26 %-36.01%
141.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Xintela Stock analysis

What does Xintela do? Xintela AB, based in Lund, Skåne, develops pharmaceutical products in the Health Care sector, specifically focusing on regenerative medicine for cartilage damage and osteoarthritis, as well as treatments for glioblastoma brain tumors. The company utilizes therapeutic antibodies and XINMARK, a marker technology using specific proteins to identify stem cells for cartilage development. Listed on 22 March 2016, Xintela operates within biotechnology, targeting innovative therapies in oncology and orthopedics. Xintela is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Xintela stock

FCF Conversion Rate (FCF/EBITDA) of Xintela is 171.39 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Xintela changed from 103.86 % to 171.39 %, representing a 65.02% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Xintela since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Xintela with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Xintela

All Key Metrics — Xintela